Leer en Español
Earlier this week, the White House announced the creation of a response group to the spread of monkeypox.
The commissioner of the Food and Drug Administration (FDA), Robert Califf, announced that his office had identified a possible solution to alleviate the lack of sufficient vaccines while authorities obtain new doses.
This solution would consist of administering one-fifth of the dose contained in a vaccine vial in an intradermal route.
Last week, health authorities announced that more than one million vaccines against the disease would be made available to the states in the coming days, of which 600,000 have already been delivered.
The national emergency declaration will also force states to share health information about monkeypox with federal authorities, which will streamline emergency response, Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky explained.
Walensky explained that the populations most at risk and the main target of the vaccination campaign are, on the one hand, men who have sex with men and who have HIV and, on the other hand, men at higher risk of contracting AIDS.
The World Health Organization (WHO) declared an international health emergency two weeks ago due to the outbreak, even though only nine deaths have been reported worldwide.
Global monkeypox cases now total 26,017, resulting in nine deaths, according to statistics updated daily by the World Health Organization (WHO).
The United States remains the country with the most reported cases, with 6,307 cases, followed by Spain (4,577), Germany (2,839), the United Kingdom (2,759), and France (2,239).
Of the nine confirmed deaths, two were reported in Spain, three in Nigeria, two in the Central African Republic, one in Ghana, and one in India. The Geneva-based agency is still confirming other possible deaths linked to the disease.